Table 1

Clinical characteristics of study patients

PatientRhythmPatient characteristics
Age (years)SexFEV1/FVC
(% predicted)
Pao2 (kPa)BSA (kg/m2)MedicationsAetiology
JWAF64M 95102.12A, LD, DDCM
CFAF69M 96142.06A, LD, N, DzICM
RLAF56M 9411.42.04A, LD, DDCM
NJAF58M11310.11.66A, LD, DDCM
SCAF59M109112.03A, LD, DDCM
MDAF60M 70101.99A, DDCM
Mean (SD)61 (4.7) 96.2 (15.1)11.1 (1.5)1.98 (0.16)
LDSR62M11510.51.77A, LD, D, NICM
JMSR57M10215.41.78A, LD, DDCM
MKSR56F11411.71.73A, LD, DICM
CKSR64M 86131.83A, LDDCM
TGSR55M 9311.61.94A, LD, NDCM
Mean (SD)58.8 (4.0)102 (12.7)12.4 (1.9)1.8 (0.1)
  • Rhythm indicates the cardiac rhythm present; AF = atrial fibrillation; SR = sinus rhythm; BSA = body surface area; PCWP = pulmonary capillary wedge pressure at baseline; A = angiotensin converting enzyme inhibitor, LD = loop diuretic, D = digoxin, N = oral nitrate, Dz = diltiazem; DCM = dilated cardiomyopathy, ICM = ischaemic cardiomyopathy.